4//SEC Filing
Zanganeh Mahkam 4
Accession 0001599298-25-000029
CIK 0001599298other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:39 PM ET
Size
13.0 KB
Accession
0001599298-25-000029
Insider Transaction Report
Form 4
Zanganeh Mahkam
DirectorCo-Chief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-01-02$9.18/sh+10,724$98,446→ 10,724 total(indirect: By Spouse)Exercise: $18.35Exp: 2035-01-02→ Common Stock (10,724 underlying)
Holdings
- 551,695,096(indirect: By Spouse)
Common Stock
- 3,985,055(indirect: By Spouse)
Warrant (right to buy)
Exercise: $1.58From: 2020-06-24Exp: 2029-12-24→ Common Stock (3,985,055 underlying) - 74,545(indirect: By Spouse)
Stock Option (right to buy)
Exercise: $2.64Exp: 2034-01-02→ Common Stock (74,545 underlying) - 25,457,666(indirect: By Trust)
Common Stock
- 50,000(indirect: Immediate family member)
Common Stock
- 31,000
Common Stock
- 10,199,776(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]The Reporting Person acquired beneficial ownership of these securities upon her marriage to the beneficial owner of the securities on December 18, 2024.
- [F3]The option was granted on January 2, 2025 to the Reporting Person's spouse. The shares underlying the option shall vest in four quarterly installments, subject to continued service on each vesting date.
- [F4]The option was granted on January 2, 2024 to the Reporting Person's spouse. The shares underlying the option are fully vested.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001507650
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:39 PM ET
- Size
- 13.0 KB